Andy’s interest in cancer research stems from his personal experience with childhood cancer. Andy’s oldest daughter is an anaplastic Wilms’ tumor survivor, leading to his interest in helping all children with cancer and a desire to make a mid-life career transition into cancer research. He is passionate about pursuing new preclinical research demonstrating more promising and less toxic treatment strategies for children with cancer and helping to make these treatments available to pediatric cancer patients in the clinical setting.
Charles Keller, MD
Scientific Director
